Most Recent
Target, Kmart accused of selling knock-off Van Cleef jewellery
Intellectual Property 2025-09-22 11:55 pm By Cat Fredenburgh

The owner of luxury brand Van Cleef & Arpels has taken retailers Target and Kmart to court, alleging they infringed its trade marks and violated consumer law by selling jewellery that copy its hallmark clover and flower motifs worn by countless celebrities and royalty.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Regeneron, Bayer take fight over Eylea biosimilar to appeals court
Intellectual Property 2025-09-17 11:50 pm By Christine Caulfield

Biotech Regeneron and drug company Bayer have wasted no time in challenging a decision that cleared the way for generic pharmaceutical manufacturer Sandoz to launch a version of top selling Eylea.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Regeneron, Bayer lose bid to block Sandoz from launching Eylea biosimilar
Intellectual Property 2025-09-08 11:55 pm By Cindy Cameronne

Regeneron and Bayer have lost their bid to block generic drug maker Sandoz from launching a biosimilar of their blockbuster eye drug Eylea.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Novartis’ last ditch bid to block Entresto generic fails
Intellectual Property 2025-08-11 11:33 pm By Cat Fredenburgh

The High Court has rejected Novartis’ plea that it overturn a ruling that found an extension of the term of the patent for its heart drug Entresto was invalidly granted.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Sandoz says Amgen ‘dragging the chain’ in fight over bone drug biosimilar
Intellectual Property 2025-05-15 11:06 pm By Andy Sidler

Sandoz has accused Amgen of ‘dragging the chain’ as the Swiss biotech continues to mull whether to launch infringement proceedings over six patents for its Prolia and Xgeve bone disease biologics.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Sandoz moves to block Amgen’s attorneys from prosecuting patents in IP spat
Intellectual Property 2025-05-06 11:41 pm By Andy Sidler

Generic drug maker Sandoz wants to shield information turned up by preliminary discovery orders from the eyes of Amgen patent attorneys in a spat over cheap versions of Amgen’s bone disease drugs, and says if they view the material they should be barred from prosecuting future related patents.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Novartis loses appeal over patent for heart drug Entresto
Intellectual Property 2025-03-24 11:50 pm By Cat Fredenburgh

Pharmacor will be allowed to sell a generic version of heart drug Entresto after the Full Court rejected Swiss drug giant Novartis’ appeal of a ruling that found an extension of the term of its patent for the drug was invalidly granted.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Novartis appeals IP win for Pharmacor over blood pressure drug
Appeals 2025-01-20 11:42 pm By Christine Caulfield

Pharmaceutical giant Novartis is challenging the loss of its case against Sydney-based generics company Pharmacor over a patent for heart medication Entresto.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Novartis loses case against Pharmacor over blood pressure drug
Intellectual Property 2024-11-13 11:44 pm By Sam Matthews

Swiss pharmaceutical giant Novartis has lost its patent infringement case against Sydney-based generics company Pharmacor over a top-selling heart medication.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Isuzu takes fight over Directed Electronics’ case to Full Court
Appeals 2024-11-01 11:48 pm By Christine Caulfield

Isuzu is not giving up its bid to slam the brakes on a suit by car alarm company Directed Electronics over alleged trade secrets theft.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?